Australia-based Microba Life Sciences commences trading on the Australian Securities Exchange following the completion o...
Australia's Telix Pharmaceuticals announced that its prostate cancer imaging agent, Illuccix (kit for preparation o...
Telix Pharmaceuticals has announced that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) P...
A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...
Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati...
Australians will have cheaper access to treatments for high cholesterol, heart failure and high blood pressure from toda...
US-based Sonoma Pharmaceuticals, a global healthcare leader developing and producing patented Microcyn technology based ...
Australian Medical device company Baymatob has completed a placement of A$4.215 million, with proceeds used to continue ...
The Coalition Government in Australia is investing in a stronger health system as part of its plan for a stronger future...
Australia-based Telix Pharmaceuticals has signed an exclusive agreement with Xiel Limited (Xiel) for the distributi...
Australia's Telix Pharmaceuticals announced that the United States Food and Drug Administration (FDA) has granted Orphan...
It is well known that ingesting psilocybin (magic mushrooms) will induce profound changes in consciousness and perceptio...
ResApp Health, a leading digital health company developing smartphone applications for the diagnosis and management of r...
Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...
Australians with cystic fibrosis will soon have access to a new treatment following the listing of Trikafta® on the ...
The Australian government is investing more than $100 million for seasonal influenza vaccines to protect Aus...
Australia's Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company developing next-generation products to...
An in-principle agreement was first announced in December last year for a factory to produce 25 million doses a year fro...
